94 related articles for article (PubMed ID: 8754404)
1. [Prevalence of response to anti-HBV infection in patients on maintenance hemodialysis infected with hepatitis C virus (HCV)].
Muszytowski M; Manitius J; Ruszkiewicz-Fołda M
Przegl Lek; 1996; 53(5):417-9. PubMed ID: 8754404
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients.
Navarro JF; Teruel JL; Mateos M; Ortuño J
Clin Nephrol; 1994 Feb; 41(2):113-6. PubMed ID: 8004827
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
4. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
Sorkhi H; Dooki MR; Ebrahimnejad MS
J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
9. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
11. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
[TBL] [Abstract][Full Text] [Related]
12. [The response to the hepatitis B virus vaccine in patients undergoing hemodialysis and peritoneal dialysis--personal experience].
Majdan M; Polz M; Ksiazek A; Janicka L; Kozioł M; Swatowski A; Orłowska G
Przegl Lek; 1995; 52(6):307-10. PubMed ID: 7568985
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: the effect of interferon-alpha therapy.
Chlabicz S; Grzeszczuk A; Łapiński TW
Med Sci Monit; 2002 May; 8(5):CR379-83. PubMed ID: 12011781
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection.
Cheng CH; Huang CC; Leu ML; Chiang CY; Wu MS; Lai PC
Vaccine; 1997; 15(12-13):1353-7. PubMed ID: 9302744
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
Urbanowicz W
Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
[TBL] [Abstract][Full Text] [Related]
19. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
